HIPK3 has been related to apoptosis resistance [27], CBR1 has been identified as a patient survival marker [24], ALDH3A1 and ALDH3A2 have been related to drug response [28], and NOS1 has been related to pancreatic cancer risk [29]. Here, NOS1 is linked to pancreatic neoplasm.